Multiple myeloma is a form of blood cancer that affects the plasma cells. In some cases, plasma cells gradually decline and cause a condition called hypogammaglobulinemia. Plasma cells are white blood ...

Sarah Hudgens is a content pro with over 15 years of experience writing and editing copy for a wide range of industry verticals and channels. Gagandeep Brar, MD, is a board-certified hematologist and ...

Multiple myeloma is a cancer of the blood that affects plasma cells, and its progression is determined using the Durie-Salmon Staging System or the Revised International Staging System (RISS). The ...

At age 89, Cal Crow plays water volleyball three days a week, then chases that with a 1,000-foot swim; on his off days, he logs at least a mile around his neighborhood — and that’s with a cancer ...

Multiple myeloma starts with genetic changes in plasma cells, which are not inherited but occur spontaneously. The condition progresses from monoclonal gammopathy of undetermined significance (MGUS) ...

Histopathological image of multiple myoloma. Smear preparation of bone marrow aspirate stained with May-Grünwald-Giemsa procedure. It doest not represent a histopathologic image but essentially helps ...

In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...

B-cell maturation antigen (BCMA)–directed chimeric antigen receptor (CAR) T-cell therapies have generated responses in patients with advanced myeloma, but relapses are common. G protein–coupled ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

Doctors often use chemotherapy for myeloma in combination with other therapies, such as stem cell transplantation or targeted therapies. This approach aims to eliminate cancer cells while minimizing ...

Sayaka Blickenderfer is a medical and science editor and writer with more than 10 years of experience. She edits and prepares scientific manuscripts and grant proposals for submission. Doru Paul, MD, ...